Genprex, Inc. — Director's Dealing 2018

Nov 7, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Genprex, Inc. (GNPX)
CIK: 0001595248
Period of Report: 2018-11-02

Reporting Person: Genprex, Inc. (Director, Chief Executive Officer, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-11-02	Stock Option (Right to Buy)	$2.15	A	551284	Acquired	2028-11-02	Common Stock (551284)	Direct

Footnotes

F1: One hundred percent (100%) of the Shares subject to the Option shall vest upon the date of grant of the Option.